The following analysts provide research coverage of Human Genome Sciences, Inc. (NASDAQ: HGSI).

Rachel McMinn
Bank of America/Merrll Lynch

Barclays Capital
Jim Birchenough, M.D

  BernsteinResearch
Geoffrey C. Porges, MBBS

Citigroup Investment Research
Yaron Werber, MD

Goldman, Sachs and Company
Davis Bu, M.D., M.A.

JMP Securities
Liisa A. Bayko

JPMorgan
Cory Kasimov 

Lazard Capital Markets
Terence C. Flynn, Ph.D.

Leerink Swann
Joseph P. Schwartz

Monness, Crespi, Hardt & Company
Avik Roy

Piper Jaffray
Edward A. Tenthoff

RBC Capital Markets
Michael Yee

R.W. Baird
Christopher J. Raymond

ThinkEquity
Brian Skorney

Thomas Wiesel Partners
Stephen Willey

UBS
Maged Shenouda, Ph.D.
 

Human Genome Sciences, Inc. ("HGS") makes no representation as to the accuracy or completeness of any of these analysts' reports. The projections and analysis therein are those of the authors of the reports, and are not endorsed by or on behalf of HGS and HGS does not undertake to update or correct any information contained therein. Factual information and opinions expressed in the reports are the responsibility of the author of the report and are subject to change.